India gives Hetero Labs and Cipla approval to make Gilead's COVID-19 drug

) experimental COVID-19 treatment remdesivir, the Indian pharmaceutical companies said on Sunday.

The drug, which will be marketed under the brand name Covifor, will likely be priced at 5,000 to 6,000 rupees for a 100 milligram dose, Hetero said.The Drug Controller General of India was not immediately available for comment. Gilead Sciences Inc signed non-exclusive licensing pacts last month with five generic drugmakers based in India and Pakistan to expand the supply of its COVID-19 treatment.

Consider:

madlurion só eu que percebi isso? Kkkkkk

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

India gives Hetero Labs approval to make Gilead's COVID-19 drugIndia's drug regulator has given Hetero Labs the green light to manufacture and market its generic version of Gilead Science's experimental COVID-19 treatment remdesivir, the Indian pharmaceutical company said on Sunday. Hetero labs? As a gay man, I'm concerned. To all the LGBTQ folks who are getting upset about the name of the pharma company, a few years back there was similar furor about Hitler Jeans. Indian choices for names do not always adhere to Western sensibilities, but malice is rarely intended. How homophobic of them
Source: Reuters - 🏆 2. / 97 Read more »